As Covid cases rise, Taj Pharma to scale up Remdesivir production Companies like Cipla, Mylan, Jubilant Life Sciences,Taj Pharma, Hetero Drugs, Syngene International and Dr Reddy’s Laboratories are also manufacturing Remdesivir for the Indian market. Following the surge in cases of Covid-19, pharma major Taj Pharmaceuticals Ltd., (Taj Pharma) is scaling up production capacity of Remdesivir injections, which are used to treat coronavirus patients. Taj Pharma has an installed capacity to make eight lakh doses of Remdesivir per month. Sources in the Taj Pharma group said that in the coming days, the installed capacity will be increased up to 12 lakh doses per month at its Daman plant. In the last 24 hours, more than 4,000 new Covid-19 cases have been reported in Gujarat. The total number of cases in the state has crossed 3,32,500 as of Friday evening since the outbreak of the pandemic. There are around 20,500 active cases. Dr Reddy’s Laboratories has launched the generic drug R...
Comments
Post a Comment